Main Goal of Late-Stage Trial is Not Achieved by AstraZeneca's Drug Combo.

Published Date: 18 Nov 2023

The pharmaceutical company AstraZeneca reported that a late-stage trial aimed at treating unresectable, stage 3 non-small cell lung cancer did not achieve the primary objective of Imfinzi, when administered in conjunction with chemoradiotherapy.

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

How access to specialized cancer centers affects glioblastoma outcomes

2.

Cancer Patients Who Completed Medication Survey Received More Help From Pharmacists

3.

Positive Trials; Malignancies Increasing in Younger Adults; Andre Braugher's Cancer Dx.

4.

U.S. Nurse Found Dead; Harvey Weinstein's Cancer; Creepy Source of Ear Pain

5.

Beyond What Is Visible in Myelofibrosis?


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot